{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:15:53Z","timestamp":1790997353695,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2022H113"],"award-info":[{"award-number":["LH2022H113"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bmc.2024.118007","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T13:36:55Z","timestamp":1732023415000},"page":"118007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K\/AKT\/mTOR pathway"],"prefix":"10.1016","volume":"117","author":[{"given":"Siqi","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Long","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.118007_b0005","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1080\/10408398.2021.1913091","article-title":"Natural products targeting into cancer hallmarks: an update on caffeine, theobromine, and (+)-catechin","volume":"62","author":"Cadon\u00e1","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.bmc.2024.118007_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1346-9","article-title":"Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer","volume":"15","author":"Greaney","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bmc.2024.118007_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2024.118007_b0020","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00520-015-2901-8","article-title":"Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients","volume":"24","author":"Lefebvre","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bmc.2024.118007_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040509","article-title":"Evolution of natural product scaffolds as potential proteasome inhibitors in developing cancer therapeutics","volume":"13","author":"Mir","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.bmc.2024.118007_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.118007_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8324696","article-title":"Natural products for the management and prevention of breast cancer","volume":"2018","author":"Mitra","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bmc.2024.118007_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3149362","article-title":"Anticancer properties of essential oils and other natural products","volume":"2018","author":"Blowman","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bmc.2024.118007_b0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.118007_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115710","article-title":"The recent developments of camptothecin and its derivatives as potential anti-tumor agents","volume":"260","author":"Wang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0055","first-page":"515","article-title":"Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies","volume":"56","author":"Muggia","year":"1972","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bmc.2024.118007_b0060","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bmcl.2016.12.085","article-title":"The long story of camptothecin: from traditional medicine to drugs","volume":"27","author":"Martino","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.118007_b0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/1570179418666210303113406","article-title":"Synthesis and anti-cancer activity of paclitaxel-coumarin conjugate","volume":"18","author":"Song","year":"2021","journal-title":"Curr Org Synth"},{"key":"10.1016\/j.bmc.2024.118007_b0070","article-title":"Proteomic profiling of paclitaxel treated cells identifies a novel mechanism of drug resistance mediated by PDCD4","volume":"14","author":"Hui","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bmc.2024.118007_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112830","article-title":"Recent advances of podophyllotoxin\/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: an update (2010-2020)","volume":"208","author":"Xiao","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0080","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1007\/s11033-022-07652-2","article-title":"A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells","volume":"49","author":"Zhao","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.bmc.2024.118007_b0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1248\/yakushi.22-00094","article-title":"Elucidation of the mechanism of topotecan-induced antitumor immune activation","volume":"142","author":"Kitai","year":"2022","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.bmc.2024.118007_b0090","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1039\/D2BM00940D","article-title":"A novel docetaxel derivative exhibiting potent anti-tumor activity and high safety in preclinical animal models","volume":"10","author":"Wang","year":"2022","journal-title":"Biomater Sci"},{"key":"10.1016\/j.bmc.2024.118007_b0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/aja.aja_40_17","article-title":"Role of chemotherapy in prostate cancer","volume":"20","author":"Nader","year":"2018","journal-title":"Asian J Androl"},{"key":"10.1016\/j.bmc.2024.118007_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116224","article-title":"Synthesis and biological evaluation of novel cabazitaxel analogues","volume":"41","author":"Ren","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.rvsc.2017.09.019","article-title":"Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model","volume":"113","author":"Ong","year":"2017","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.bmc.2024.118007_b0110","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1021\/jf900581h","article-title":"Cytotoxic activities of 9,11-dehydroergosterol peroxide and ergosterol peroxide from the fermentation mycelia of ganoderma lucidum cultivated in the medium containing leguminous plants on Hep3B cells","volume":"57","author":"Chen","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/0929867323666151127200949","article-title":"Natural endoperoxides as drug lead compounds","volume":"23","author":"Bu","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1615\/IntJMedMushrooms.2020036673","article-title":"Ergosterol peroxide isolated from oyster medicinal mushroom, Pleurotus ostreatus (agaricomycetes), potentially induces radiosensitivity in cervical cancer","volume":"22","author":"Meza-Menchaca","year":"2020","journal-title":"Int J Med Mushrooms"},{"key":"10.1016\/j.bmc.2024.118007_b0125","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1039\/C9FO02454A","article-title":"Ergosterol peroxide from Pleurotus ferulae inhibits gastrointestinal tumor cell growth through induction of apoptosis via reactive oxygen species and endoplasmic reticulum stress","volume":"11","author":"Yang","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.bmc.2024.118007_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36411-2","article-title":"Ergosterol peroxide from marine fungus Phoma sp. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.118007_b0135","doi-asserted-by":"crossref","first-page":"33948","DOI":"10.18632\/oncotarget.8608","article-title":"Ergosterol peroxide activates foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2024.118007_b0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jep.2015.07.030","article-title":"Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the \u03b2-catenin pathway in colorectal cancer","volume":"173","author":"Kang","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2024.118007_b0145","first-page":"3627","article-title":"Mechanism of ergosterol peroxide in treatment of breast cancer based on network pharmacology and experimental validation","volume":"49","author":"Luo","year":"2024","journal-title":"Chin J Chin Mater Med"},{"key":"10.1016\/j.bmc.2024.118007_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107862","article-title":"Design and synthesis of novel mitochondria-targeted ergosterol peroxide derivatives as potential anti-cancer agents","volume":"153","author":"Wang","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29184375","article-title":"Discovery and optimization of ergosterol peroxide derivatives as novel glutaminase 1 Inhibitors for the treatment of triple-negative breast cancer","volume":"29","author":"Luo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.118007_b0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2017.05.013","article-title":"Synthesis and biological evaluation of novel steroidal 5\u03b1,8\u03b1-endoperoxide derivatives with aliphatic side-chain as potential anticancer agents","volume":"124","author":"Bu","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.bmc.2024.118007_b0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cmdc.201700021","article-title":"Synthesis of 5\u03b1,8\u03b1-ergosterol peroxide 3-carbamate derivatives and a fluorescent mitochondria-targeting conjugate for enhanced anticancer activities","volume":"12","author":"Bu","year":"2017","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","article-title":"Thiazolidinediones as antidiabetic agents: a critical review","volume":"77","author":"Nanjan","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47157-x","article-title":"Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-\u03b3 agonists","volume":"13","author":"Najmi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.118007_b0180","article-title":"An update on the current and emerging use of thiazolidinediones for type 2 diabetes","volume":"58","author":"Giglio","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bmc.2024.118007_b0185","first-page":"3177","article-title":"Heterogeneity of PTEN and PPAR-\u03b3 in cancer and their prognostic application to bladder cancer","volume":"18","author":"Zhang","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2024.118007_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8679271","article-title":"PPAR-\u03b3 ligand inhibits nasopharyngeal carcinoma cell proliferation and metastasis by regulating E2F2","volume":"2019","author":"Yang","year":"2019","journal-title":"PPAR Res"},{"key":"10.1016\/j.bmc.2024.118007_b0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.bmc.2024.118007_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107003","article-title":"New thiophene-1,3,4-oxadiazole-thiazolidine-2,4-dione hybrids: synthesis, MCF-7 inhibition and binding studies","volume":"143","author":"Doddagaddavalli","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cmdc.202000458","article-title":"Synthesis and biological evaluation of pyrazoline and pyrrolidine-2,5-dione hybrids as potential antitumor agents","volume":"15","author":"Tilekar","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2024.118007_b0210","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2174\/1568026621666210521143550","article-title":"Thiazolidinedione: a privileged scaffold for the development of anticancer agents","volume":"21","author":"Sun","year":"2021","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2174\/1389557519666191029102838","article-title":"An insight into the synthesis and SAR of 2,4-thiazolidinediones (2,4-TZD) as multifunctional scaffold: a review","volume":"20","author":"Sethi","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0220","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/cmdc.201402320","article-title":"From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents","volume":"9","author":"Wu","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2024.118007_b0225","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bmc.2012.01.050","article-title":"Cyclic dipeptides exhibit potency for scavenging radicals","volume":"20","author":"Furukawa","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.118007_b0230","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.bmcl.2016.07.017","article-title":"Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterse ainhibitors with neuroprotective activity","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.118007_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115543","article-title":"Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K\/mTOR dual inhibitor for the treatment of acute myeloid leukemia","volume":"258","author":"Yang","year":"2023","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624004218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T09:01:00Z","timestamp":1737795660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624004218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"alternative-id":["S0968089624004218"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118007","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K\/AKT\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.118007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118007"}}